282 related articles for article (PubMed ID: 11815392)
1. Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.
Valjent E; Mitchell JM; Besson MJ; Caboche J; Maldonado R
Br J Pharmacol; 2002 Jan; 135(2):564-78. PubMed ID: 11815392
[TBL] [Abstract][Full Text] [Related]
2. Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice.
Balerio GN; Aso E; Berrendero F; Murtra P; Maldonado R
Eur J Neurosci; 2004 Nov; 20(10):2737-48. PubMed ID: 15548217
[TBL] [Abstract][Full Text] [Related]
3. Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression.
Boucher AA; Hunt GE; Karl T; Micheau J; McGregor IS; Arnold JC
Neuroscience; 2007 Nov; 149(4):861-70. PubMed ID: 17905522
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic nicotine exposure on Δ
Miladinovic T; Manwell LA; Raaphorst E; Malecki SL; Rana SA; Mallet PE
Pharmacol Biochem Behav; 2020 Jul; 194():172931. PubMed ID: 32353393
[TBL] [Abstract][Full Text] [Related]
5. Mouse cerebellar nicotinic-cholinergic receptor modulation of Delta9-THC ataxia: role of the alpha4beta2 subtype.
Smith AD; Dar MS
Brain Res; 2006 Oct; 1115(1):16-25. PubMed ID: 16934231
[TBL] [Abstract][Full Text] [Related]
6. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
Célérier E; Ahdepil T; Wikander H; Berrendero F; Nyberg F; Maldonado R
Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
[TBL] [Abstract][Full Text] [Related]
7. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
[TBL] [Abstract][Full Text] [Related]
8. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Panagis G; Hildebrand BE; Svensson TH; Nomikos GG
Synapse; 2000 Jan; 35(1):15-25. PubMed ID: 10579804
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.
Soria G; Castañé A; Berrendero F; Ledent C; Parmentier M; Maldonado R; Valverde O
Eur J Neurosci; 2004 Oct; 20(8):2203-13. PubMed ID: 15450100
[TBL] [Abstract][Full Text] [Related]
10. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
Jardinaud F; Roques BP; Noble F
Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of nicotine on restraint stress-induced anxiety-like behavior, c-Fos expression, and corticosterone release in mice.
Hsu HR; Chen TY; Chan MH; Chen HH
Eur J Pharmacol; 2007 Jul; 566(1-3):124-31. PubMed ID: 17459372
[TBL] [Abstract][Full Text] [Related]
12. Behavioral cross-tolerance between repeated intracerebellar nicotine and acute Delta(9)-tetrahydrocannabinol-induced cerebellar ataxia: role of cerebellar nitric oxide.
Smith AD; Dar MS
J Pharmacol Exp Ther; 2007 Jul; 322(1):243-53. PubMed ID: 17416741
[TBL] [Abstract][Full Text] [Related]
13. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
14. Acetaldehyde, a major constituent of tobacco smoke, enhances behavioral, endocrine, and neuronal responses to nicotine in adolescent and adult rats.
Cao J; Belluzzi JD; Loughlin SE; Keyler DE; Pentel PR; Leslie FM
Neuropsychopharmacology; 2007 Sep; 32(9):2025-35. PubMed ID: 17287824
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the alpha4beta2 nicotinic receptor subtype in nicotine-induced attenuation of delta9-THC cerebellar ataxia: role of cerebellar nitric oxide.
Smith AD; Dar MS
Pharmacol Biochem Behav; 2007 Jan; 86(1):103-12. PubMed ID: 17275078
[TBL] [Abstract][Full Text] [Related]
16. Acute behavioural responses to nicotine and nicotine withdrawal syndrome are modified in GABA(B1) knockout mice.
Varani AP; Moutinho LM; Bettler B; Balerio GN
Neuropharmacology; 2012 Oct; 63(5):863-72. PubMed ID: 22727822
[TBL] [Abstract][Full Text] [Related]
17. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.
Cadoni C; Valentini V; Di Chiara G
J Neurochem; 2008 Aug; 106(4):1586-93. PubMed ID: 18513369
[TBL] [Abstract][Full Text] [Related]
18. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.
Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
J Neurochem; 2005 May; 93(4):984-91. PubMed ID: 15857401
[TBL] [Abstract][Full Text] [Related]
19. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol.
Hutcheson DM; Tzavara ET; Smadja C; Valjent E; Roques BP; Hanoune J; Maldonado R
Br J Pharmacol; 1998 Dec; 125(7):1567-77. PubMed ID: 9884086
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
